Literature DB >> 9125245

Elevated cytokine messenger RNA levels in the peripheral blood of patients with rheumatoid arthritis suggest different degrees of myeloid cell activation.

H Schulze-Koops1, L S Davis, A F Kavanaugh, P E Lipsky.   

Abstract

OBJECTIVE: To determine whether monocytes in rheumatoid arthritis (RA) are activated to produce proinflammatory cytokines in the peripheral circulation before entering the synovium and whether the pattern of cytokines that is expressed correlates with disease activity.
METHODS: Cytokine messenger RNA (mRNA) levels were assessed in peripheral blood mononuclear cells (PBMC) from 14 RA patients and 14 healthy controls by semiquantitative reverse transcription-polymerase chain reaction technology. The method employed was sufficiently sensitive to assess cytokine mRNA levels in freshly isolated cells without the necessity of in vitro stimulation. Thus, an estimate of the in vivo state of activation could be obtained.
RESULTS: Interleukin-8 (IL-8) mRNA levels were elevated in all 14 RA patients compared with normal controls, whereas 7 of 14 RA patients had elevated levels of mRNA for IL-6 or IL-10. IL-1beta mRNA levels were below the normal range in 3 of 14 patients, within normal limits in 4 of 14, and elevated in 7 of 14. Tumor necrosis factor alpha mRNA levels were within the normal range in 9 of 14 patients and below normal in 5 of 14. There was a statistically significant difference between the mean IL-10 (P < 0.05) and IL-8 (P < 0.001) mRNA levels in RA patients and normal controls. Of note, the 7 patients with elevated IL-1beta mRNA levels also expressed the highest levels of IL-8 mRNA. Whereas a strong correlation between the expression of IL-1beta and IL-8 mRNA (P < 0.001) was found, expression of all other mRNA occurred independently of each other. Levels of cyclooxygenase 2 (COX-2) mRNA were also determined to evaluate the status of myeloid cell activation more completely. COX-2 mRNA levels were within the normal range in 4 of 11 patients and below normal in 7 of 11, but did not correlate with the expression of any of the cytokine mRNA.
CONCLUSION: Elevated levels of mRNA for selected cytokines that are predominantly produced by monocytes can be found in the PBMC of many RA patients. The data indicate that myeloid precursor cells become activated to produce cytokines before they enter the synovium, a finding which emphasizes the systemic nature of RA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9125245     DOI: 10.1002/art.1780400408

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  12 in total

1.  Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis.

Authors:  P Barrera; L A Joosten; A A den Broeder; L B van de Putte; P L van Riel; W B van den Berg
Journal:  Ann Rheum Dis       Date:  2001-07       Impact factor: 19.103

2.  Immunomodulatory effects of vitamin D in peripheral blood monocyte-derived macrophages from patients with rheumatoid arthritis.

Authors:  Anna Neve; Addolorata Corrado; Francesco Paolo Cantatore
Journal:  Clin Exp Med       Date:  2013-07-04       Impact factor: 3.984

3.  Hypercalcemia in rheumatoid arthritis: relationship with disease activity and bone metabolism.

Authors:  Peter Oelzner; Gabriele Lehmann; Thorsten Eidner; Sybille Franke; Andreas Müller; Gunter Wolf; Gert Hein
Journal:  Rheumatol Int       Date:  2006-01-11       Impact factor: 2.631

4.  Peripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targets.

Authors:  Bertalan Mesko; Szilard Poliska; Andrea Szegedi; Zoltan Szekanecz; Karoly Palatka; Maria Papp; Laszlo Nagy
Journal:  BMC Med Genomics       Date:  2010-05-05       Impact factor: 3.063

5.  Honokiol possesses potential anti-inflammatory effects on rheumatoid arthritis and GM-CSF can be a target for its treatment.

Authors:  Xiao-Dong Wang; Ying-Liang Wang; Wen-Feng Gao
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

6.  Molecular profile of peripheral blood mononuclear cells from patients with rheumatoid arthritis.

Authors:  Christopher J Edwards; Jeffrey L Feldman; Jonathan Beech; Kathleen M Shields; Jennifer A Stover; William L Trepicchio; Glenn Larsen; Brian Mj Foxwell; Fionula M Brennan; Marc Feldmann; Debra D Pittman
Journal:  Mol Med       Date:  2007 Jan-Feb       Impact factor: 6.354

7.  Gene expression profiles of disc tissues and peripheral blood mononuclear cells from patients with degenerative discs.

Authors:  Yin-gang Zhang; Xiong Guo; Zhengming Sun; Guanghui Jia; Peng Xu; Shijie Wang
Journal:  J Bone Miner Metab       Date:  2009-10-02       Impact factor: 2.626

8.  Liposomal encapsulation enhances and prolongs the anti-inflammatory effects of water-soluble dexamethasone phosphate in experimental adjuvant arthritis.

Authors:  Rebecca Anderson; Angels Franch; Margarida Castell; Francisco J Perez-Cano; Rolf Bräuer; Dirk Pohlers; Mieczyslaw Gajda; Alexandros P Siskos; Theodora Katsila; Constantin Tamvakopoulos; Una Rauchhaus; Steffen Panzner; Raimund W Kinne
Journal:  Arthritis Res Ther       Date:  2010-07-19       Impact factor: 5.156

9.  Mononuclear Phagocytes in Rheumatoid Arthritis Patients and their Relatives - Family Similarity.

Authors:  Marina I Arleevskaya; Aida G Gabdoulkhakova; Julia V Filina; Aleksey I Zabotin; Anatoly P Tsibulkin
Journal:  Open Rheumatol J       Date:  2011-10-18

Review 10.  Macrophages in rheumatoid arthritis.

Authors:  R W Kinne; R Bräuer; B Stuhlmüller; E Palombo-Kinne; G R Burmester
Journal:  Arthritis Res       Date:  2000-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.